These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28840310)

  • 1. Topical cis-urocanic acid prevents ocular surface irritation in both IgE -independent and -mediated rat model.
    Jauhonen HM; Laihia J; Oksala O; Viiri J; Sironen R; Alajuuma P; Kaarniranta K; Leino L
    Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2357-2362. PubMed ID: 28840310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ketotifen fumarate, olopatadine, and levocabastine on ocular active anaphylaxis in the guinea pig and ocular immediate hypersensitivity in the albino rat.
    Schoch C
    Ocul Immunol Inflamm; 2005 Feb; 13(1):39-44. PubMed ID: 15804768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA
    J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Application of Interleukin-28A Attenuates Allergic Conjunctivitis in an Ovalbumin-Induced Mouse Model.
    Chen J; Zhang J; Zhao R; Jin J; Yu Y; Li W; Wang W; Zhou H; Su SB
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):604-10. PubMed ID: 26886894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice.
    Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C
    Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis.
    Kato M; Kurose T; Oda T; Miyaji S
    J Ocul Pharmacol Ther; 2003 Aug; 19(4):315-24. PubMed ID: 12964956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effects of galectin-1 on an IgE-mediated allergic conjunctivitis model.
    Mello CB; Ramos L; Gimenes AD; Andrade TR; Oliani SM; Gil CD
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):693-704. PubMed ID: 25574053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase I clinical study of cis-urocanic acid eye drops in healthy adult subjects.
    Jauhonen HM; Kari E; Pylkkänen L; Poutanen J; Laihia J; Kaarniranta K; Leino L
    Acta Ophthalmol; 2015 Jun; 93(4):368-76. PubMed ID: 25611308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
    Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring conjunctival tolerance by topical nuclear factor-κB inhibitors reduces preservative-facilitated allergic conjunctivitis in mice.
    Guzmán M; Sabbione F; Gabelloni ML; Vanzulli S; Trevani AS; Giordano MN; Galletti JG
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(9):6116-26. PubMed ID: 25190648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE and non-IgE mechanisms in ocular allergy.
    Bonini S; Bonini S
    Ann Allergy; 1993 Sep; 71(3):296-9. PubMed ID: 8373003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV; Udell IJ
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells.
    Yanni JM; Miller ST; Gamache DA; Spellman JM; Xu S; Sharif NA
    Ann Allergy Asthma Immunol; 1997 Dec; 79(6):541-5. PubMed ID: 9433371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saikosaponin A inhibits compound 48/80-induced pseudo-allergy via the Mrgprx2 pathway in vitro and in vivo.
    Wang N; Che D; Zhang T; Liu R; Cao J; Wang J; Zhao T; Ma P; Dong X; He L
    Biochem Pharmacol; 2018 Feb; 148():147-154. PubMed ID: 29274317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model.
    Berdy GJ; Spangler DL; Bensch G; Berdy SS; Brusatti RC
    Clin Ther; 2000 Jul; 22(7):826-33. PubMed ID: 10945509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis.
    Mortemousque B; Bourcier T; Khairallah M; Messaoud R; Brignole-Baudouin F; Renault D; Rebika H; Brémond-Gignac D;
    J Fr Ophtalmol; 2014 Jan; 37(1):1-8. PubMed ID: 24388379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound 48/80-induced conjunctivitis in the mouse: kinetics, susceptibility, and mechanism.
    Li Q; Luyo D; Hikita N; Whitcup SM; Chan CC
    Int Arch Allergy Immunol; 1996 Mar; 109(3):277-85. PubMed ID: 8620098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated T cells in an animal model of allergic conjunctivitis.
    Carreras I; Carreras B; McGrath L; Rice A; Easty DL
    Br J Ophthalmol; 1993 Aug; 77(8):509-14. PubMed ID: 8025049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.